Edith Mirzaian, PharmD, BCACP
Faculty Directory

Edith MirzaianPharmD, BCACP

Edith MirzaianPharmD, BCACP

Associate Professor of Clinical Pharmacy and Associate Dean of Curriculum

Titus Family Department of Clinical Pharmacy

Edith Mirzaian is an associate professor of clinical pharmacy at USC Mann. She earned her doctor of pharmacy from USC in 2001 and completed a residency in community-based pharmacy practice in 2002. She is a board-certified ambulatory care pharmacist and holds the Certificate of Knowledge in Travel Health from the International Society of Travel Medicine.

Mirzaian has served the USC community-based pharmacy residency programs in various capacities since 2005, including preceptor, site coordinator and residency program director. She currently serves as assistant dean of curriculum, oversees the USC community pharmacy–based patient care programs and coordinates and teaches in several courses in the PharmD curriculum.

She established and served for seven years as director of the USC Medication Management Center, which provides health plans and pharmacy benefit manager solutions to exceed Centers for Medicare & Medicaid Services–mandated medication therapy management (MTM) goals and improve medication adherence and patient satisfaction with MTM services. She is a national faculty trainer for the American Pharmacists Association Pharmacy Based Immunization Training Program, Travel Health and Diabetes Care Program. She and has implemented numerous community pharmacy and clinic-based collaborative practice and patient care programs including travel health, diabetes, anticoagulation, hepatitis C, and smoking cessation clinics and multiphasic disease state screenings.

Areas of Expertise

  • Pharmacy Education
  • Improving STAR ratings in MTM Services in Medicare Populations
  • Immunizations and Vaccine-Preventable Diseases
  • International Travel Health
  • Collaborative Practice Implementation and Compensation Mechanism for Clinical Pharmacy Services
  • Diabetes Management
  • Education

    University of Southern California


  • Links
  • Selected Articles

    Mosquito‐Borne Illnesses in Travelers: A Review of Risk and Prevention

    Edith Mirzaian Pharm.D. Melissa J. Durham Pharm.D. Karl Hess Pharm.D. Jeffery A. Goad Pharm.D., M.P.H.

    2012 In 2008, residents of the United States made 12 million visits to developing countries in Asia, South America, Central America, Oceania, the Middle East, and Africa. Due to the presence of Anopheles, Aedes, and Culex mosquitoes, travel to these destinations poses a risk for diseases such as malaria, yellow fever, and Japanese encephalitis that cause significant morbidity and mortality. To gain a better understanding of the major emerging and established travel‐related infectious diseases transmitted principally by mosquitoes and the measures for their prevention in U.S. residents who travel to these developing countries, we performed a literature search of the PubMed and MEDLINE databases (January 1950–February 2010). Information from the Centers for Disease Control and Prevention and the World Health Organization and relevant references from the publications identified were also reviewed. Vaccines for the prevention of Japanese encephalitis and yellow fever are commercially available to U.S. travelers and should be administered when indicated. However, the prevention of malaria, dengue fever, chikungunya, and West Nile virus relies on personal insect protection measures and chemoprophylaxis for malaria. As the rate of international travel continues to rise, individuals traveling overseas should be made aware of the risk of various infectious diseases and the importance of prevention. Physicians, pharmacists, nurses, and other practitioners can play a vital role in disease education and prevention, including the administration of vaccines and provision of chemoprophylactic drugs.

    Read More

  • Accomplishments

    Certificate of Knowledge in Travel Health

    Awarded from the International Society of Travel Medicine

  • Selected Media Appearances

    APhA Recognizing Professionwide Award Recipients

    Pharmacy Times | 03/22/2019

    Edith Mirzaian, PharmD, BCACP, whose involvement in the community residency training program at the University of Southern California School of Pharmacy, is recognized by this award, which is presented to a community pharmacy residency director or preceptor who has demonstrated excellence in precepting, mentoring, leadership, and community pharmacy residency program administration...

    Read More

    New Hampshire Mother of 4 Dies of Flu Complications After Deciding Not to Take Tamiflu

    People | 01/31/2018

    Edith Mirzaian, an associate professor of clinical pharmacy at the University of Southern California School of Pharmacy, says Tamiflu is one of the primary medications used to treat influenza. Though it has rare adverse side effects, it has proven to be effective...

    Read More

    USC School of Pharmacy Selects the MirixaPro(SM) Platform

    PR NewsWire | 02/12/2015

    Edith Mirzaian, PharmD, Assistant Professor of Clinical Pharmacy at USC Mann commented, "Since the need for quality medication therapy management services has become increasingly important, we have developed a Medication Management Center to implement innovative methods of MTM delivery that provide solutions for our community. Using the MirixaPro platform will help us serve the needs of our clients effectively."...

    Read More